文献速递认知障碍与痴呆

主观认知下降或轻度认知障碍前状态个体的脑代谢与淀粉样蛋白负荷

Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment.
PubMed 文献 · Neurology · 2022-07-18

这项多中心研究纳入105例主观认知下降(SCD=49)或轻度认知障碍前状态(pre-MCI=56)个体,基线行认知与神经行为评估、FDG-PET及淀粉样蛋白PET。FDG-PET正常者占45%,脑低代谢者占55%,以额叶样模式最常见(28%);神经精神症状患病率78%;接受淀粉样蛋白PET者(n=60)中18%淀粉样负荷异常。主成分分析提取的神经心理与神经精神因子分别与特定脑区低代谢相关。

要点

  • SCD与pre-MCI人群FDG-PET表现异质:45%正常、55%脑低代谢,额叶样模式最常见(28%)。
  • 神经精神症状在本样本中患病率高(78%)。
  • 接受淀粉样蛋白PET者(n=60)中18%淀粉样负荷异常。

核心结论

  • FDG-PET证据提示SCD与pre-MCI个体或脑功能正常、或呈现不同模式的脑低代谢,这些人群具有异质性。
  • 不同的神经心理与神经精神特征与特定脑区的神经元功能障碍相关。
  • 需要长期随访研究评估这些状态进展为痴呆的风险。

研究设计与样本

  • 多中心研究,数据来自Network-AD项目(NET-2011-02346784)。
  • 纳入105例参与者(SCD=49,pre-MCI=56),基线接受认知与神经行为评估、FDG-PET及淀粉样蛋白PET。
  • 采用主成分分析(PCA)识别独立的神经心理与神经精神维度及其与脑代谢的关联。

主要发现

  • FDG-PET正常者占45%,脑低代谢者占55%,额叶样模式为最常见发现(28%)。
  • 源自神经精神问卷与Starkstein淡漠量表的神经精神症状在全样本中高度常见(78%)。
  • 接受淀粉样蛋白PET的参与者(n=60)中18%检出淀粉样负荷异常。
  • 神经心理PCA提取3个因子:执行/视运动因子与额叶、枕叶皮质及基底节低代谢相关;记忆因子与颞顶区低代谢相关;视空间/构造因子与额顶皮质低代谢相关。
  • 神经精神PCA提取2个因子:情感因子与眶额、扣带皮质及岛叶低代谢相关;多动/精神病性因子与额叶、颞叶及顶叶区域低代谢相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要长期随访研究评估这些状态进展为痴呆的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: This was a multicenter study aimed at investigating the characteristics of cognitive decline, neuropsychiatric symptoms, and brain imaging in individuals with subjective cognitive decline (SCD) and subtle cognitive decline (pre-mild cognitive impairment [pre-MCI]). METHODS: Data were obtained from the Network-AD project (NET-2011-02346784). The included participants underwent baseline cognitive and neurobehavioral evaluation, FDG-PET, and amyloid PET. We used principal component analysis (PCA) to identify independent neuropsychological and neuropsychiatric dimensions and their association with brain metabolism. RESULTS: A total of 105 participants (SCD = 49, pre-MCI = 56) were included. FDG-PET was normal in 45% of participants and revealed brain hypometabolism in 55%, with a frontal-like pattern as the most frequent finding (28%). Neuropsychiatric symptoms emerging from the Neuropsychiatric Inventory and the Starkstein Apathy Scale were highly prevalent in the whole sample (78%). An abnormal amyloid load was detected in the 18% of the participants who underwent amyloid PET (n = 60). PCA resulted in 3 neuropsychological factors: (1) executive/visuomotor, correlating with hypometabolism in frontal and occipital cortices and basal ganglia; (2) memory, correlating with hypometabolism in temporoparietal regions; and (3) visuospatial/constructional, correlating with hypometabolism in frontoparietal cortices. Two factors emerged from the neuropsychiatric PCA: (1) affective, correlating with hypometabolism in orbitofrontal and cingulate cortex and insula; (2) hyperactive/psychotic, correlating with hypometabolism in frontal, temporal, and parietal regions. DISCUSSION: FDG-PET evidence suggests either normal brain function or different patterns of brain hypometabolism in SCD and pre-MCI. These results indicate that SCD and pre-MCI represent heterogeneous populations. Different neuropsychological and neuropsychiatric profiles emerged, which correlated with neuronal dysfunction in specific brain regions. Long-term follow-up studies are needed to assess the risk of progression to dementia in these conditions.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Tondo G, Boccalini C, Vanoli EG, et al. Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment. Neurology. 2022. PMID: 35487700. doi:10.1212/WNL.0000000000200351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。